ロード中...
Producing proT cells to promote immunotherapies
T lymphocytes are critical mediators of the adaptive immune system and they can be harnessed as therapeutic agents against pathogens and in cancer immunotherapy. T cells can be isolated and expanded from patients and potentially generated in vitro using clinically relevant systems. An ultimate goal...
保存先:
| 出版年: | Int Immunol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6234910/ https://ncbi.nlm.nih.gov/pubmed/30102361 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/intimm/dxy051 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|